Home / Brands / The Compounding Pharmacy of America
The Compounding Pharmacy of America Recalls
383 recalls on record · September 23, 2015 to February 21, 2018 · Drugs
Recalls by year
15
18
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Zinc Chloride 25mg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville,
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Zinc 5 mg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Vancomycin 25 mg/ml Ophthalmic Solution, Single Dose, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxvil
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 75 mg and B12 6 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 200 mg Anastrazole 9 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 200 mg Anastrazole 1 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 60 mg Anastrazole 4 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 80 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 75 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 72.5 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 70 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 62.5 mg Pellet, Sterile, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone 50 mg Pellet, Sterile, The Compounding Pharmacy of America, Inc., Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone USP (10 AQUEOUS) 100 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Propionate 100 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Ame
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone USP Aqueous 200 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Am
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Enanthate 200 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Amer
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 200 mg/ml Anastrazole 0.25 mg/ml Cholecalciferol 50,000 U/ml, Injectable, Multi-Dose Vial, Steril
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 200 mg/ml Anastrazole 2 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compound
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 200 mg/ml Anastrazole 0.5 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Com
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 200 mg/ml Anastrazole 0.25 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compo
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 200mg/ml Injection Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Americ
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 150 mg/ml Injection Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Ameri
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Testosterone Cypionate 100 mg/ml Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of Amer
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls SUPER LIPO Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sufentanil 50 mcg/ml + Bupivacaine 0.25 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America,
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sufentanil 50 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sufentanil 45 mcg/ml + Bupivacaine 5 mg/ml Solution, Sterile=Preservative Free, The Compounding Pharmacy of America, Kno
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sodium Tetradecyl Sulfate 5% Injectable, Multi-Dose Vial, Sterile, Refrigerate, The Compounding Pharmacy of America, Kno
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
September 23, 2015DrugsFDA
The Compounding Pharmacy of America recalls Sodium Ascorbate 500 mg/ml Injection, Preservative Free Vial, Sterile, Refrigerate, The Compounding Pharmacy of America,
Hazard: Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility